From Traditional Use to Molecular Mechanisms: A Critical Review of the Pharmacological Potential of Opuntia cochenillifera (L.) Mill.

Wilfred A; Sahaya Mary C

doi:10.36948/ijfmr.2026.v08i05.88860

From Traditional Use to Molecular Mechanisms: A Critical Review of the Pharmacological Potential of Opuntia cochenillifera (L.) Mill.

Author(s)	Mr. Wilfred A, Dr. Sahaya Mary C
Country	India
Abstract	The escalating global burden of antimicrobial resistance, chronic inflammatory disease and metabolic disorders has intensified the search for structurally diverse bioactive compounds from medicinal plants. Opuntia cochenillifera (L.) Mill. (syn. Nopalea cochenillifera ), a succulent cactus native to Mexico and widely naturalized across tropical and subtropical regions, is a historically important yet pharmacologically underexplored member of the Cactaceae. This review consolidates and critically evaluates the species-specific botanical, ethnobotanical, phytochemical, pharmacological and toxicological evidence published between 2015 and 2026. The cladodes contain a distinctive phytochemical profile dominated by phenolic acids, including gallic acid (2708.49 microg/g), ferulic acid (796.73 microg/g), chlorogenic acid (179.70 microg/g), p-coumaric acid (80.58 microg/g), syringic acid (11.12 microg/g) and neochlorogenic acid (9.52 microg/g), together with isorhamnetin-3-O-(2'',3''-O-di-rhamnose)-glucoside as the major polyphenolic peak, and a polysaccharide-rich mucilage with a water-holding capacity of 2.78 g/g and an oil-holding capacity of 1.80 g/g. The most robust evidence supports anti-inflammatory and gastroprotective activities mediated through downregulation of NF-kB p65 and MAPK1/ERK2 signalling, reduction of IL-1beta and TNF-alpha, elevation of IL-10, and attenuation of MDA and MPO. Antimicrobial and antioxidant findings remain inconsistent and are strongly influenced by extraction solvent, plant part and assay methodology. Emerging evidence supports antihyperglycaemic effects that appear independent of potent alpha-glucosidase inhibition, together with mucilage biocompatibility suited to biomedical applications and accelerated wound healing in diabetic models. An acute toxicity study at 2000 mg/kg revealed no mortality or adverse biochemical or haematological alterations. Nevertheless, methodological heterogeneity, limited bioassay-guided fractionation, the absence of clinical trials and persistent taxonomic confusion between O. cochenillifera and its synonym N. cochenillifera constrain direct comparison and translational extrapolation. Future investigations should prioritize taxonomically authenticated material, chemically standardized extracts, network-pharmacology-guided mechanistic studies, and rigorous preclinical dose-response and toxicological evaluation as prerequisites for clinical translation.
Keywords	Opuntia cochenillifera; Nopalea cochenillifera ; Ethnopharmacology; Phenolic Compounds; Anti-Inflammatory Activity; NF-kappaB; MAPK Signalling; Mucilage; Polypharmacology; Network Pharmacology
Field	Biology > Agriculture / Botany
Published In	Volume 8, Issue 5, September-October 2026
Published On	2026-10-03
DOI	https://doi.org/10.36948/ijfmr.2026.v08i05.88860

View / Download PDF File

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

From Traditional Use to Molecular Mechanisms: A Critical Review of the Pharmacological Potential of Opuntia cochenillifera (L.) Mill.

Share this